Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01372800 |
Recruitment Status : Unknown
Verified November 2011 by Xijing Hospital.
Recruitment status was: Recruiting
First Posted : June 14, 2011
Last Update Posted : November 21, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Myocardial Infarction Cerebral Infarction |
Study Type : | Observational |
Estimated Enrollment : | 30000 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Serum Adiponectin Concentration, Activity and Isoforms in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases |
Study Start Date : | May 2011 |
Estimated Primary Completion Date : | October 2016 |
Group/Cohort |
---|
volunteer |
- Number of Participants with major adverse events [ Time Frame: 5 years ]Major adverse events included but were not limited to death during the study caused by cardiovascular events or cerebrovascular events.
- blood routine, glucose and lipid profile; ECG; [ Time Frame: 5 years ]the tests mentioned above will be taken once per year
- serum adiponectin concentration, activity and isoforms [ Time Frame: 5 years ]serum adiponectin concentration, activity and isoforms will be monitored once per year.
Biospecimen Retention: None Retained

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 85 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- available for 5 years of follow-up study
Exclusion Criteria:
- Death caused other than cardiovascular and cerebralvascular diseases till the study ends
- Floating Population
- Pregnancy, lactation, or child bearing women
- Tumor
- Active hepatic disease or hepatic dysfunction, or AST/ALT > 1.5UNL
- Severe renal dysfunction(Scr > 3 mg/dl or 264μmol/L)
- Patients with any condition which, in the investigator's judgment, might increase the risk to the subject for any adverse event or abnormal laboratory finding

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01372800
Contact: Ling Tao, M.D Ph.D | +86-15002955798 | lingtao2006@gmail.com |
China, Shaanxi | |
Xijing Hospital | Recruiting |
Xi'an, Shaanxi, China, 710032 | |
Contact: Ling Tao, M.D Ph.D +86-15002955798 lingtao2006@gmail.com | |
Principal Investigator: Ling Tao, M.D Ph.D |
Responsible Party: | Xijing Hospital |
ClinicalTrials.gov Identifier: | NCT01372800 |
Other Study ID Numbers: |
xj050503 |
First Posted: | June 14, 2011 Key Record Dates |
Last Update Posted: | November 21, 2013 |
Last Verified: | November 2011 |
adiponectin cardiovascular diseases cerebrovascular diseases |
Cerebral Infarction Cerebrovascular Disorders Myocardial Infarction Infarction Ischemia Pathologic Processes Necrosis Myocardial Ischemia Heart Diseases |
Cardiovascular Diseases Vascular Diseases Brain Infarction Brain Ischemia Brain Diseases Central Nervous System Diseases Nervous System Diseases Stroke |